Anika Therapeutics reported $28.96M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8881M 534M
Acceleron Pharma XLRN:US $ 91.6M 3.24M
Acorda Therapeutics ACOR:US $ 47.47M 10.17M
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Agenus AGEN:US $ 77.12M 24.04M
Agios Pharmaceuticals AGIO:US $ 89.22M 2M
Anika Therapeutics ANIK:US $ 28.96M 4.07M
Arrowhead Research ARWR:US $ 77.76M 16.72M
Chemocentryx CCXI:US $ 40.55M 871K
Clovis Oncology CLVS:US $ 94.4M 1.66M
Dicerna Pharmaceuticals DRNA:US $ 81.58M 4.87M
Enanta Pharmaceuticals ENTA:US $ 55.47M 5.64M
Flexion Therapeutics FLXN:US $ 45.06M 2.67M
Halozyme Therapeutics HALO:US $ 43.41M 15.84M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Immunogen IMGN:US $ 44.32M 305K
Insmed INSM:US $ 151.62M 27.57M
Integra Lifesciences IART:US $ 338.14M 10.37M
Intrexon XON:US $ 49.25M 7.06M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Ligand Pharmaceuticals LGND:US $ 38.94M 16.3M
Macrogenics MGNX:US $ 71.04M 2.86M
Merit Medical Systems MMSI:US $ 271.43M 36.71M
Peregrine Pharmaceuticals PPHM:US $ 23.82M 695K
Rigel Pharmaceuticals RIGL:US $ 39.31M 51K
Sangamo Biosciences SGMO:US $ 76.57M 3.99M
Stryker SYK:US $ 3.57B 82M
Surmodics SRDX:US $ 26.26M 745K
Veracyte VCYT:US $ 62.58M 19.54M
Xencor XNCR:US $ 58.36M 8.72M
Zimmer Biomet Holdings Inc ZBH:US $ 1.81B 224.6M